GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Marketable Securities

Nortem Biogroup (XPAR:MLBIO) Marketable Securities : €0.10 Mil (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Nortem Biogroup's Marketable Securities for the quarter that ended in Dec. 2022 was €0.10 Mil.

Nortem Biogroup's annual Marketable Securities increased from . 20 (€0.00 Mil) to Dec. 2021 (€0.12 Mil) but then declined from Dec. 2021 (€0.12 Mil) to Dec. 2022 (€0.10 Mil).

Nortem Biogroup Marketable Securities Historical Data

The historical data trend for Nortem Biogroup's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Marketable Securities Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Marketable Securities
0.12 0.10

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Marketable Securities 0.12 0.10

Nortem Biogroup Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Nortem Biogroup  (XPAR:MLBIO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Nortem Biogroup Marketable Securities Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Marketable Securities
Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Website
https://www.nortembiogroup.com
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines